Results 41 to 50 of about 29,630 (214)

Intracellular Concentrations of Fosfomycin in Alveolar Macrophages from Weaning Piglets [PDF]

open access: yes, 2015
At weaning, piglets are more susceptible to infectious diseases, being respiratory syndromes one of the most frequent conditions. Fosfomycin is indicated for the treatment of a variety of porcine bacterial pathogens, with MIC90 ranging between 0.25-0.50 ...
Dieguez, Susana Nelly   +6 more
core   +2 more sources

Plasma and Urine Pharmacokinetics of Oral Fosfomycin Tromethamine in Dogs

open access: yesVeterinary Sciences, 2023
Fosfomycin is a broad-spectrum, bactericidal antibiotic with low toxicity. It has been used in human medicine and is a promising candidate for treating infections in veterinary medicine.
Nattha Jariyapamornkoon   +2 more
doaj   +1 more source

Antimicrobials: a global alliance for optimizing their rational use in intra-abdominal infections (AGORA) [PDF]

open access: yes, 2016
Intra-abdominal infections (IAI) are an important cause of morbidity and are frequently associated with poor prognosis, particularly in high-risk patients.
A   +173 more
core   +4 more sources

Draft genome sequences of three newly identified species in the genus Cronobacter, C. helveticus LMG23732T, C. pulveris LMG24059, and C. zurichensis LMG23730T [PDF]

open access: yes, 2013
Cronobacter helveticus, Cronobacter pulveris, and Cronobacter zurichensis are newly described species in the Cronobacter genus, which is associated with serious infections of neonates.
Dickins, B   +7 more
core   +1 more source

The Detection of Fosfomycin-Modifying Enzymes (fos) in Uropathogenic Enterobacterale, Azerbaijan, Iran

open access: yesCanadian Journal of Infectious Diseases and Medical Microbiology, 2023
Enterobacteriaceae is the most common agent of urinary tract infections (UTIs). Multidrug resistant (MDR) and XDR (extensively drug-resistant) Enterobacteriaceae in UTIs have increased in the world.
Aidin Lalezadeh   +2 more
doaj   +1 more source

Synergistic Combination of Linezolid and Fosfomycin Closing Each Other’s Mutant Selection Window to Prevent Enterococcal Resistance

open access: yesFrontiers in Microbiology, 2021
Enterococci, the main pathogens associated with nosocomial infections, are resistant to many common antibacterial drugs including β-lactams, aminoglycosides, etc.
Lifang Jiang   +13 more
doaj   +1 more source

Pharmacodynamics of Aerosolized Fosfomycin and Amikacin against Resistant Clinical Isolates of Pseudomonas aeruginosa and Klebsiella pneumoniae in a Hollow-Fiber Infection Model: Experimental Basis for Combination Therapy [PDF]

open access: yes, 2016
There has been a resurgence of interest in aerosolization of antibiotics for treatment of patients with severe pneumonia caused by multidrug-resistant pathogens.
Hope, William W   +8 more
core   +1 more source

Efficacy of Fosfomycin against Planktonic and Biofilm-Associated MDR Uropathogenic Escherichia coli Clinical Isolates

open access: yesTropical Medicine and Infectious Disease, 2022
Urinary tract infections (UTI) are a severe public health problem and are caused mainly by the uropathogenic Escherichia coli (UPEC). Antimicrobial resistance and limited development of new antimicrobials have led to the reuse of old antibiotics such as ...
Haziel Eleazar Dzib-Baak   +5 more
doaj   +1 more source

Synergistic effect of fosfomycin and fluoroquinolones against Pseudomonas aeruginosa growing in a biofilm. [PDF]

open access: yes, 2005
Ulifloxacin is the active form of the prodrug prulifloxacin and shows a highly potent antipseudomonal activity. In this study, we examined the combined effect of fosfomycin and ulifloxacin against Pseudomonas aeruginosa (P.
Hikida, Muneo   +5 more
core   +1 more source

Screening for Fosfomycin Resistance Genes in Carbapenem- Resistant Isolates of Enterobacterales from the Bloodstream of Liver Transplant Patients

open access: yesMediterranean Journal of Infection, Microbes and Antimicrobials, 2022
Introduction: Interest in fosfomycin, an old antibiotic, has been reignited because of the use of its intravenous formulation (fosfomycin sodium) in resistant infections.
Yakup GEZER   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy